Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 13.88 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: crospovidone; microcrystalline cellulose; trehalose dihydrate; glycerol dibehenate; calcium hydrogen phosphate; light magnesium oxide; magnesium stearate; sodium starch glycollate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine; amlodipine besylate - tablet - 5mg/5 milligram(s) - ace inhibitors and calcium channel blockers; perindopril and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine; amlodipine besylate - tablet - 5mg/10 milligram(s) - ace inhibitors and calcium channel blockers; perindopril and amlodipine

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 5 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maltodextrin; colloidal anhydrous silica; glycerol dibehenate; sodium starch glycollate type a; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; glycerol dibehenate; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; maltodextrin; glycerol dibehenate; sodium starch glycollate type a; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type a; glycerol dibehenate; magnesium stearate; lactose monohydrate; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; maltodextrin; glycerol dibehenate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; sodium starch glycollate type a; maltodextrin; magnesium stearate; glycerol dibehenate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.